Truncating presenilin mutations and their effects on gamma-secretase activity, tau and beta-catenin
Truncating presenilin mutations and their effects on gamma-secretase activity, tau and beta-catenin
批准号:
nhmrc : 453622
负责人:
A/Pr Michael Lardelli
金额:
$27.61万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's disease (AD) and cancer are increasingly important both in terms of human suffering and the burden of care it imposes on society and the economy. Sporadic (non-inherited) AD is the most common form of dementia but is poorly understood. The PRESENILIN genes, PSEN1 and PSEN2, are the major sites for mutations causing inherited AD and are also implicated in cancer. Using the zebrafish embryo model we have discovered that, contrary to current thought, mutations that truncate presenilin proteins potently suppress normal presenilin activity. (They are so called, dominant negatives). This means that they are lethal for embryo development and explains why such mutations have never been found in inherited AD. Notably, this discovery could only be made using a subtle form of gene manipulation that is possible in zebrafish embryos. Our work has also established the first assay for the non-apoptotic (non-cell death) function of PSEN2 and has shown that PSEN2 activity is inhibited by truncated PSEN1. This is the first indication of possible interaction between PSEN1 and PSEN2 proteins at normal physiological expression levels. Loss of presenilin activity promotes cancer. Truncated presenilin proteins could be produced by errors in gene transcription (aberrant transcript splicing) common in cancerous cells. This suggests that truncated, dominant negative forms of presenilin produced through aberrant splicing (or mutation in precancerous cells) might be common in tumour formation. The proposed research will define the region of PSEN1 in which truncation leads to dominant negative activity. This will allow further examination of the role of presenilins in the cell signalling pathways involved in AD and cancer. We will also investigate the role that age-related truncation of presenilins in human cells can play in the formation of sporadic AD. This may reveal a common molecular link between the inherited and sporadic forms of this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying early molecular changes underlying familial Alzheimer’s disease
-
批准号:nhmrc : 1126422
-
项目类别:Project Grants
-
资助金额:$51.57万
-
财政年份:2017
-
负责人:A/Pr Michael Lardelli
-
依托单位:
Identifying early molecular changes underlying familial Alzheimer’s disease
-
批准号:nhmrc : GNT1126422
-
项目类别:Project Grants
-
资助金额:$75.58万
-
财政年份:2017
-
负责人:A/Pr Michael Lardelli
-
依托单位:
Defining the changes in cell biology caused by PRESENILIN truncations associated with different diseases
-
批准号:nhmrc : 1061006
-
项目类别:Project Grants
-
资助金额:$41.53万
-
财政年份:2014
-
负责人:A/Pr Michael Lardelli
-
依托单位:
Analysis of the function of the presenilin genes during embryogenesis.
-
批准号:nhmrc : 104870
-
项目类别:NHMRC Project Grants
-
资助金额:$13.16万
-
财政年份:2000
-
负责人:A/Pr Michael Lardelli
-
依托单位:
国内基金
海外基金
登录
查看更多内容
电刺激调控下的诱导多向潜能干细胞移植对缺血性卒中的神经修复作用及其Presenilin1信号机制研究
-
批准号:81701230
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:刘倩
-
依托单位:
应用心肌特异基因敲除小鼠探讨presenilin 1在心力衰竭中的功能与机制
-
批准号:81760076
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2017
-
负责人:胡淑婷
-
依托单位:
早老素Presenilin介导的免疫调控及其在神经退行性疾病中的作用
-
批准号:31470040
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2014
-
负责人:钱旻
-
依托单位:
膜蛋白酶Presenilin在膀胱癌恶性进展过程中的表达及分子机制研究
-
批准号:81302231
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2013
-
负责人:瓦斯里江·瓦哈甫
-
依托单位:
Presenilin功能缺失对大脑线粒体及凋亡途径的影响及其分子基础
-
批准号:31171019
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:赵政
-
依托单位:
PEN-2在Arf6导致的胰腺癌细胞黏附连接解体中的分子机制探讨
-
批准号:81101839
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:魏树梅
-
依托单位:
microRNAs对PS1/PS2双基因敲除致小鼠神经退行性病变调控机制的研究
-
批准号:81070876
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:梅兵
-
依托单位:
早老素突变对树突棘内F-actin重组分子调控机制和生物学意义
-
批准号:30670414
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2006
-
负责人:崔德华
-
依托单位:
中国家族性阿尔茨海默病发病机制的实验研究
-
批准号:30370494
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2003
-
负责人:贾建平
-
依托单位: